Introduction of drug cost analysis system under consideration.

Published: 2002-04-15 07:00:00

Updated: 2002-04-15 07:00:00

To eliminate a drug price bubble the MOHW mulls an adoption of so called "Drug Cost Analysis" system from coming June, which requires submission of the drug price cost statement at the time of new NHI price registration. Besides, the MOHW also tries to launch a model project of the Reference Pric...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK